ID   LSM 2.7
AC   CVCL_IU06
DR   Wikidata; Q54903113
RX   Patent=US4529694;
RX   PubMed=6365856;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8121.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2516 ! HS-Sultan
CA   Hybrid cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
RX   Patent=US4529694;
RA   Lazarus H., Schwaber J.F.;
RT   "Cell fusion.";
RL   Patent number US4529694, 16-Jul-1985.
//
RX   PubMed=6365856; DOI=10.1016/0198-8859(84)90041-7;
RA   Schwaber J.F., Posner M.R., Schlossman S.F., Lazarus H.;
RT   "Human-human hybrids secreting pneumococcal antibodies.";
RL   Hum. Immunol. 9:137-143(1984).
//